TYLE PRAVEEN 4
4 · Skye Bioscience, Inc. · Filed Mar 4, 2024
Insider Transaction Report
Form 4
TYLE PRAVEEN
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-02-29+35,000→ 35,000 totalExercise: $14.56Exp: 2034-03-01→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The option grant shall be exercisable for a price of $14.56 per option share for ten years from February 29, 2024 and the options will vest in equal monthly installments over the one year period beginning February 29, 2024.